On the record · Investment firm
1315 Capital
Research depth
Transactions sourced
At least one recorded transaction has a public source.
Record updated Oct. 13, 2026
Current ownership
Current owner not established
This record does not identify a current owner. That absence is a gap in the record, not a conclusion about ownership.
Ownership and transaction history
Chronology from recorded ownership periods, transactions and reviewed outcome events. Event order does not imply causation.
Sept. 10, 2020
ProSciento, Inc. / 1315 Capital
Minority investment · Completed · Recorded transaction
Jan. 13, 2020
Interpace Biosciences, Inc. / 1315 Capital, Ampersand Capital Partners
Minority investment · Announced · Recorded transaction
Date not recorded
Other · Completed · Recorded transaction
Sources and evidence
Recorded transaction sources
These support a recorded transaction row. They have not passed the separate evidence-review process.
- R1ProSciento Closes Growth Financing from 1315 Capital
ProSciento · Company announcement · Sept. 10, 2020
Supports: Recorded transaction
- R2Interpace Biosciences Enters into Agreement for $20 Million Investment from 1315 Capital and Ampersand Capital Partners
Ampersand Capital Partners · Company announcement · Jan. 6, 2020
Supports: Recorded transaction
- R3NutriSense | 1315 Capital
1315 Capital · Investment-firm portfolio page · Retrieved Oct. 3, 2026
Supports: Recorded transaction
What we do not know
These are gaps in the public record, not findings about the organization.
- The organization's operating status has not been researched.
- No current public ownership assessment has been published.
Help improve this record
Firsthand experience, public sources and corrections can help close the gaps above.